INAHTA

New publications

Short-Acting Agents for Procedural Sedation and Analgesia in Canadian Emergency Departments: A Review of Clinical Outcomes and Economic Evaluation (HTA Checklist)
Polyclonal Intravenous Immunoglobulin in Patients with Immune Thrombocytopenic Purpura: Clinical Systematic Review (HTA Checklist)
Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis (HTA Checklist)
Reprocessing of single-use medical devices: Clinical, economic, and health services impact (HTA Checklist)
Reprocessing of Single-Use Medical Devices: National Survey of Canadian Acute-Care Hospitals (HTA Checklist)
Fetal Fibronectin Test for Preterm Labor (INAHTA Briefs)

About INAHTA

INAHTA (International Network of Agencies for Health Technology Assessment) a non-profit organization was established in 1993 and has now grown to 47 member agencies from 23 countries including North and Latin America, Europe, Australia, and New Zealand. All members are non-profit making organizations producing HTA and are linked to regional or national government.

Many organizations throughout the world assess healthcare technology. There is an evident need to cooperate and share information from different cultures. INAHTA serves this purpose. The Secretariat is located at SBU in Sweden.

Mission

INAHTA´s mission is to provide a forum for the identification and pursuit of interests common to HTA agencies. The network aims to:

Accelerate exchange and collaboration among agencies